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Summary The binding of misonidazole (MISO) to macromolecules in hypoxic cells is believed to require
metabolic reduction. Several factors in the cells' environment, such as pH, glucose, lactate and MISO
concentration could affect the capacity of metabolic reduction. Modulation of the binding of MISO by these
factors was studied by exposing exponential EMT6/Ro cells to MISO under extremely hypoxic conditions. No
binding was observed under aerobic conditions. There was no difference in the binding of 0.02mM MISO at
varying concentrations of glucose from 0.015mM to 5 mm. Thus, for diagnostic purposes with concentrations
of MISO lower than 0.02mm, little effect of glucose concentration is expected. However, with 5 mm MISO,
the binding of MISO increased with increasing glucose concentration (3-fold increase after 2 hours incubation
in 5 mm glucose relative to 0.015 mm glucose). At intermediate MISO concentrations (0.1 mm to 5 mM) the
higher the MISO concentration, the greater was the increase in binding due to 5 mM glucose. There was no
detectable effect of lactate (0, 3 and 10mM) at pH 7.2 on the binding of MISO either in 0.015mM or 5mM
glucose. However, a decrease of pH (from 7.2 to 6.5) decreased the binding of MISO in 5 mM glucose but not
in 0.015mm glucose. These data indicated that the binding of MISO is a multi-step process, which involves
the concentrations of both glucose (probably via reducing equivalents) and MISO.
Misonidazole (MISO), an electron-affinic compound, is
preferentially toxic to hypoxic cells. It is also preferentially
reduced by hypoxic cells to reactive products that bind to
cellular molecules such as nucleic acids and proteins (Olive &
McCalla, 1977). Damage to these molecules could result in
observed biochemical alterations, e.g. disruption of DNA
synthesis (Olive, 1979) and the compromise of cellular
respiration (Varnes & Biaglow, 1982) which could lead to
cytotoxicity.
The supply of reducing equivalents in mammalian cultures
depends on the availability of the substrates. Glucose, an
initial substrate for glycolysis and the hexose monophos-
phate pathway, is one major exogenous substrate known to
affect the availability of reducing equivalents. Lactate is
another metabolite that can result in the reduction of NAD
during its conversion to pyruvate. In solid tumours, glucose
concentration may be low concurrently with high lactate
concentration in vivo. This is generally assumed to be due to
the poorly organized vasculature which gives rise to
inefficient blood flow and poor tissue oxygenation which
necessitates anaerobic glycolysis. Lactic acid when
inefficiently removed renders a more acid intestinal pH in
tumours than in normal tissue, as shown in several animal
and human tumours (Van den Berg et al., 1982; Wike-
Hooley, 1985). Low pH could inhibit glycolysis which would
decrease the reductive capacity of the cell (Ceccarini, 1975).
Such changes in pH and the availability of such substances
as glucose and lactate that can supply reducing equivalents
may modify the extent to which MISO binds to hypoxic
cells.
There is current interest in the use of MISO as a
diagnostic agent for areas of local hypoxia in the body. For
such use, it is important that the selective binding of MISO
be minimally altered by factors other than oxygen. In
addition to oxygen, concentrations of glucose, lactate and
pH are known to vary among tumours and perhaps spatially
and temporally in the same tumour (Streffer et al., 1980;
Tannock, 1968; Thomlinson & Gray, 1955). This study
examines the influence of varying pH, glucose, and lactate
concentrations on the binding of different concentrations of
MISO to the acid-insoluble fraction of extremely hypoxic
cells.
Materials and methods
Cell culture
EMT6/Ro cells were maintained as monolayers in
continuous exponential growth in BME (Eagles Basal
Medium, Grand Island Biological Co., NY) supplemented
with 15% foetal calf serum (Flow Laboratories, Inc.,
MacLean, VA), 4.7 x 10-2 mgml-' L-glutamine (GIBCO,
NY), 0.1 mgml- 1 streptomycin, 96 uml- 1 penicillin. The
cells were grown in a humidified incubator at 37°C in an
atmosphere of 3% CO2 in air. The cells were subcultured
twice weekly by dissociation with 0.01% lyophilized trypsin
(Worthington Biochemical Corp, Freehold, NJ) in sodium
citrate buffer, pH 7.2, and routinely checked for mycoplasma
contamination (Chen, 1977).
For these studies, exponential cell cultures were
dissociated with 0.01 % trypsin and concentrated to
106 cellsml -l in BME media with different amounts of
glucose and lactate added. The cells and MISO were
continuously gassed separately with 3% CO2 in nitrogen for
1.5 h at 37 C in glass chambers with continuous gentle
stirring. After hypoxia of less than 100 ppm oxygen was
induced (Mulcahy, 1984), hypoxic MISO was added to the
cell suspension. At different times, aliquots of cells were
removed for different analyses.
Binding Of 14C-MISO
Binding of 14C-MISO (labelled at C-2 of the imidazole ring)
to cells was determined by adding 14C_MISO (0.5yCirml-1)
to the cells. After different times of incubation, 1 ml of the
cell suspension was removed and spun down. The pellet was
washed with 1 ml of ice-cold saline solution before
resuspension in 1 ml of ice-cold 10% trichloroacetic acid
(TCA). After 10min, the TCA precipitate was washed once
with 1 ml of ice-cold IO% TCA and then counted in Sml of
scintillation fluid (Scintiverse, Fisher Company).
The purity of MISO and 14C-MISO was determined by
the isocratic HPLC elution method, using Waters Radial-
PAK reversed-phase bonded octadecylsilane (C18) cartridge
column. The HPLC profile of 14C-MISO was shown to be
concurrent with the radioactive counts per minute of each
fraction. This indicates that the radioactivity of the 14C-
MISO (specific activity 20.3mCimmol-1), obtained from the
National Cancer Institute, was associated with MISO.
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Results
Radioactive MISO was used to study the binding to the
acid-insoluble fraction under conditions where the pH,
concentrations of glucose, lactate, and MISO were varied.
Figure 1 shows that the binding of 5mM 14C-MISO to the
acid-insoluble fraction was significant only in hypoxic cells
and under this condition, binding increases in the presence
of glucose. Previous experiments (Ling & Sutherland, 1986b)
have shown that the amount of binding depends on glucose
concentration. From 0.015mm to 5mm glucose, there was a
3-fold increase in binding of 14C-MISO after 2 h of
incubation.
Figure I also shows that the presence of 3mM lactate had
no significant effect on binding of 14C-MISO to hypoxic
cells incubated in either 0.015mm or 5 mm glucose at an
incubation pH of 7.2. However, when pH was reduced from
7.2 to 6.5, there was a decrease in binding with time, with
cells incubated with 5 mm glucose but not in 0.015mM
glucose (Figure 2).
Figure 3 shows that the increase in binding of MISO with
time associated with increasing concentrations of glucose did
not occur when MISO concentration was decreased to 20pM.
The incubation medium was maintained at pH7.2. Again,
binding was significant only for hypoxic cells. For all
concentrations of glucose examined, from 0.015 mm to 5mm,
there was an increase in binding which leveled off at
0.15nmol MISO 10-6 cells after 1.5h of hypoxic incubation.
This amount is very much smaller than that observed for
5mM MISO which varied from 2.5nmol MISO 10-6 cells at
0.015mM glucose to 5.5nmol MISO at 5mM glucose after
1.5 h of hypoxic incubation.
To determine the concentration of MISO at which glucose
had an effect, hypoxic EMT6/Ro cells were incubated in
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Figure 1 Effect of oxygen, glucose, and lactate on the binding of
'4C-misonidazole to EMT6/Ro cells. Datum points are the
means+s.e. of replicates from 2 (for lactate) and 4 (for oxygen
and glucose) experiments.
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Figure 2 Effect of lowering pH from 7.2 to 6.5 on the binding
of '4C-misonidazole to hypoxic cells incubated in either 0.015 or
5 mm glucose. Datum points are the means +s.e. of replicates
from 2-4 experiments.
either 0.015 mM or 5 mm glucose and concentrations of
MISO varying from 0.02mM to 5mM, and 0.5,uCiml-1 of
14C-MISO for 2.5 h. When the counts per minute were
normalized to nmoles MISO bound based on specific activity
(Figure 4), in both 0.015mm and 5mm glucose, there was an
increase in MISO bound with increasing MISO
concentrations. However, only at the very low MISO
concentration of 0.02mm, was a similar amount of MISO
bound to cells regardless of glucose concentration. At all
MISO concentrations greater than 0.02 mm MISO, cells
incubated at 5mm glucose had a higher amount of MISO
bound than cells incubated at 0.015 mm glucose. This
difference increased with increasing MISO concentrations.
Thus for cells incubated in 5mm glucose, the amount of
MISO bound increased almost linearly with increasing MISO
concentrations. However, for cells incubated in 0.015mM
glucose, there seems to be a biphasic increase in the amount
of MISO bound with increasing MISO concentrations. There
was an initial relatively linear increase with increasing MISO
concentrations, up to 1 mm, which was then followed by a
more gradual increase for higher MISO concentrations.
Therefore, the greater the MISO concentration, the greater
was the difference in increase of binding due to 5 mm
glucose. This is shown in Figure 5, where the ratio of MISO
bound at 5mM glucose to that bound at 0.015mM glucose
was plotted against the concentration of MISO used. There
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Figure 3 Amount of '4C-misonidazole bound with time of
hypoxic incubation to the acid-insoluble fraction of EMT6/Ro
cells in 0.02 mM misonidazole and different concentrations of
glucose. Datum points are the means+s.e. of 4 experiments.
was an initial fast increase due to the presence of glucose at
concentrations of MISO less than I mm, followed by a
gradual increase up to 5mM.
Discussion
Metabolic reduction of MISO is believed to be essential for
its reaction in hypoxic cells such as preferential binding to
intracellular macromolecules (Chapman et al., 1983; Raleigh
et al., 1981; Olive, 1980; Varghese & Whitmore, 1976;
McCalla et al., 1970). The first reduction step to the nitro
radical is reversible by oxygen. Our data show no significant
binding of MISO to aerobic cells. This is consistent with the
premise that reduction products subsequent to the nitro
radical are responsible for the binding of MISO to macro-
molecules in hypoxic cells (Koch et al., 1984).
Metabolites of MISO are also shown to accumulate in
intact cells during hypoxic incubation. They bind to a variety
of intracellular macromolecules including DNA, RNA, and
proteins (Josephy et al., 1980; Koch et al., 1984; Varghese,
1983; Miller et al., 1983). The binding ratio between
cytoplasm and nucleus reflects the relative volumes of these
cell compartments (Miller et al., 1983). The acid-insoluble
fraction obtained in this study consisted of at least 80% of
the total DNA and 80% of the total proteins. Previous
studies have shown that this binding of MISO to the acid-
insoluble fraction is of high affinity, as indicated by the lack
of exchange of radioactive MISO with non-radioactive
MISO even after 20h of incubation (Ling et al., 1986).
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Figure 4 Amounts of 14C-misonidazole bound to the acid-
insoluble fraction of EMT6/Ro cells (106) after 2.5 h of hypoxic
incubation in different concentrations of misonidazole. Datum
points are the means+s.e. of 3 experiments.
Concentrations of oxygen, glucose and lactate are known
to vary among tumours and both spatially and temporally in
the same tumours (Tannock, 1968; Thomlinson & Gray,
1955; Streffer et al., 1980). More recently, variable glucose
concentrations have been demonstrated within histological
sections of tumours using a novel bioluminescence assay
(Mueller-Klieser et al., 1987). It has been established that
some tumours have a more acid interstitial pH than normal
tissues. This study concentrates on the effect of varying pH,
concentrations of glucose, lactate, and MISO on the binding
of MISO to the acid-insoluble fraction of hypoxic cells.
Binding of MISO could be important for both therapeutic
and diagnostic purposes.
As Figures 1 and 2 show, for hypothetical hypoxic tumour
conditions of low glucose, high lactate and low pH, it is low
glucose that governs the overall decrease in the binding of
5mM MISO. Lactate has no significant effect either at high
or low glucose and the decrease in binding seen at low pH is
significant when glucose also is low.
In hypoxic cells, glucose is the initial substrate for the
supply of adenosine triphosphate through glycolysis and
reducing equivalents through the hexose monophosphate
pathway. Decreased activity of. the hexose monophosphate
pathway due to lack of glucose (Ling & Sutherland, 1986)
could result in a lack of reducing equivalents available for
the metabolic reduction of MISO. As Figure 1 indicates, the
concentration of glucose can modify the binding of 5 mm
14C-MISO to hypoxic cells. The lower the glucose
concentration, the lower was the amount of MISO bound.
However, the amount of MISO bound at very low glucose
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Figure 5 Stimulation of the binding of '4C-misonidazole to the
acid-insoluble fraction of hypoxic cells by 5mm glucose. Cells
were indicated for 2.5 h in varying concentrations of
misonidazole and either 0.015mm glucose or 5mm glucose. Data
points are the means + s.e. of 3 experiments.
MISO bound in 5mM glucose
MISO bound in 0.015mM glucose
concentration in hypoxic cells is significantly more than in
aerobic cells.
This increase in the amount of MISO bound to the cells
due to availability of glucose is not observed when the
MISO is decreased to the very low concentration of 0.02mM.
At this low concentration of MISO, there is a similar
increase in amount of 14C-MISO bound which gradually
levelled off after 1.5 h of hypoxic incubation, for all
concentrations of glucose used from 0.015 mm to 5mM.
However, the amount of MISO bound (0.15 nmol 10-6 cells)
is very low when compared to the amount seen in cells
incubated in 5 mm MISO. This amount of MISO bound may
be the maximum binding possible for this concentration of
MISO. The results indicate that for this amount of MISO
reduction and binding, the basal level of reducing
equivalents available even in the very low glucose
concentration of 0.015 mm is sufficient.
The amount of MISO bound increases with increasing
MISO concentrations in hypoxic cells incubated either in
0.015mM or 5mM glucose. This implies that for both
concentrations of glucose, the greater the concentration of
MISO, the better MISO can compete for the process(es)
which leads to successful binding.
However, the increase in binding of MISO with increasing
MISO concentrations is greater for cells incubated in
glucose. When the concentration of MISO is increased above
0.02 mm (0.1 mm to 5 mM), the amount bound can be
modified (increased) by the availability of glucose. The
higher the MISO concentration, the greater was the increase
in binding due to 5mm glucose. This may indicate that the
binding of MISO to macromolecules is a multi-step process.
This is not unexpected. Should the hydroxylamine derivative
of MISO be the reactive species, reduction itself to the
reactive species may consist of several steps from the parent
compound to the four-electron reduction product (hydroxy-
lamine). Also to obtain a bound MISO, not only does MISO
have to be reduced to be reactive, but after reduction, it
must find the appropriate site of the macromolecule for
successful binding. Even after reduction to reactive species,
binding may not be successful if there are intracellular
species that can oxidize it.
There is an increasing stimulation in binding of MISO by
5 mm glucose with increasing MISO concentration, which is
non-linear. This non-linear increase in the stimulation of
binding by glucose with increasing MISO concentration
(Figure 4) identifies two factors, viz. MISO and glucose
concentration, that control the extent of binding to hypoxic
cells. At the very low MISO concentration of 0.02mM, in the
extreme hypoxic conditions in these experiments, the
presence of glucose does not alter the level of binding. This
is consistent with the results of Franko (Franko, 1986). This
indicates that in this condition, the concentration of MISO is
limiting the extent of binding. At higher MISO
concentrations, the presence of glucose can increase the
binding of MISO, from 1.3 times at 0.1 mm MISO to 2.8
times at 5mM MISO. This indicates that lack of glucose,
probably via reducing equivalents, can also limit the extent
of binding of MISO. Thus, for diagnostic imaging of
hypoxic areas in which MISO concentration used is lower
than 0.02mM (Urtasun et al., 1986), little effect of glucose is
expected. However, glucose effect could be important for
chemosensitization and cytotoxicity where doses of MISO
applied are much greater.
The initial rate of binding of 14C-MISO to hypoxic cells
has been shown to increase with increasing MISO
concentrations (Chapman et al., 1983; Koch et al., 1984).
Our data demonstrated that at MISO concentrations above
0.02 mm, glucose concentration is a major environmental
factor, which could modify the binding of MISO to hypoxic
cells. Low glucose decreased the amount of binding of MISO
in hypoxic cells. Further work is needed to determine the
minimum concentration of glucose at which this effect is
eliminated and to establish the influence of the degree of
hypoxia on the effects of glucose concentration on MISO
binding and cytotoxicity. It is also important to measure the
glucose level in more tumours as well as the achieveable
MISO concentrations in tumours when MISO is used as
either a therapeutic or diagnostic agent.
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